BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,067,000 | +8.6% | 1,100,000 | +10.0% | 0.14% | +5.1% |
| Q2 2023 | $982,268 | -4.3% | 1,000,000 | 0.0% | 0.14% | -4.2% |
| Q1 2023 | $1,025,979 | -3.3% | 1,000,000 | 0.0% | 0.14% | -1.4% |
| Q4 2022 | $1,061,300 | +7.1% | 1,000,000 | 0.0% | 0.14% | -2.0% |
| Q3 2022 | $991,000 | +0.1% | 1,000,000 | 0.0% | 0.15% | +2.8% |
| Q2 2022 | $990,000 | -1.0% | 1,000,000 | 0.0% | 0.14% | +16.1% |
| Q1 2022 | $1,000,000 | -4.4% | 1,000,000 | 0.0% | 0.12% | +2.5% |
| Q4 2021 | $1,046,000 | +2.2% | 1,000,000 | 0.0% | 0.12% | -7.6% |
| Q3 2021 | $1,023,000 | -1.3% | 1,000,000 | 0.0% | 0.13% | +0.8% |
| Q2 2021 | $1,036,000 | +2.4% | 1,000,000 | 0.0% | 0.13% | +0.8% |
| Q1 2021 | $1,012,000 | +88.5% | 1,000,000 | +100.0% | 0.13% | +92.5% |
| Q4 2020 | $537,000 | – | 500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |